BODALCHEM Bodal Chemicals Q4 FY25 results (Jan–Mar 2025) and concall
Bodal Chemicals delivered strong Q4 and FY25 results, driven by improved volumes and realizations across segments. The implementation of anti-dumping duty on TCCA is a significant positive, expected to boost the business. While the Turkey subsidiary continues to face hyperinflationary challenges, the company is optimistic about growth in FY26, targeting ₹1,900 crores+ revenue and 11-12% EBITDA margins, supported by increased utilization in benzene derivatives and Chlor-Alkali expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 429 | 443 | 451 |
| EBITDA | 33 | 44 | 47 |
| Net profit | 0 | 5 | 14 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
